Several evidences suggest that AF is burdened by an enhanced systemic inflammatory status [2] and platelet activation [3, 4], as shown by the enhanced release of soluble CD40 ligand (sCD40L), which may affect AF-related thromboembolic events [5]. The gene discussed is CD40LG; the disease is atrial fibrillation.